NCT02265809 - Adaptive Study of IL-2 Dose Frequency on Regulatory T Cells in Type 1 Diabetes | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 3, 2014

Primary Completion Date

May 26, 2016

Study Completion Date

May 26, 2016

Conditions

Type 1 Diabetes

Interventions

DRUG

Aldesleukin

Trial Locations (1)

Wellcome Trust Clinical Research Facility, Addenbrookes Hospital, Cambridge

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

University of Cambridge

OTHER

collaborator

Sir Jules Thorn Charitable Trust

UNKNOWN

collaborator

Juvenile Diabetes Research Foundation

OTHER

collaborator

Wellcome Trust

OTHER

collaborator

National Institute for Health Research, United Kingdom

OTHER_GOV

lead

Cambridge University Hospitals NHS Foundation Trust

OTHER